APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Growth Hormone Deficiency (Ghd) Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Growth Hormone Deficiency (Ghd) Drug Industry Growth and Trends Forecast to 2032

Report ID 173999740129 December 2025114 pages

Choose your research edition.

Industry ResearchHuman Growth Hormone Deficiency (Ghd) Drug Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Growth Hormone Deficiency (Ghd) Drug Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Human Growth Hormone Deficiency (Ghd) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Growth Hormone Deficiency (Ghd) Drug Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Growth Hormone Deficiency (Ghd) Drug Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Human Growth Hormone Deficiency (Ghd) Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Growth Hormone Deficiency (Ghd) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Growth Hormone Deficiency (Ghd) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Growth Hormone Deficiency (Ghd) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Growth Hormone Deficiency (Ghd) Drug include Teva Pharmaceutical Industries, Ltd, Merck KGaA, Eli Lilly and Company, Versartis Inc., Strongbridge Biopharma, Sandoz International GmbH (Novartis AG), Pfizer Inc, Opko Health, Inc. and Novo Nordisk A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Growth Hormone Deficiency (Ghd) Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Growth Hormone Deficiency (Ghd) Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Growth Hormone Deficiency (Ghd) Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Growth Hormone Deficiency (Ghd) Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Growth Hormone Deficiency (Ghd) Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Growth Hormone Deficiency (Ghd) Drug Market by Company

Teva Pharmaceutical Industries, Ltd

Merck KGaA

Eli Lilly and Company

Versartis Inc.

Strongbridge Biopharma

Sandoz International GmbH (Novartis AG)

Pfizer Inc

Opko Health, Inc.

Novo Nordisk A/S

LG Life Sciences

Ipsen S.A.

GeneScience Pharmaceuticals Co. Ltd

Genentech, Inc (Roche)

Ferring Pharmaceuticals

EMD Serono Inc.

Ascendis Pharma A/S

AnkeBio Co. Ltd

Human Growth Hormone Deficiency (Ghd) Drug Segment by Type

Somavaratan

Somapacitan

TransCon-hGH

Others

Human Growth Hormone Deficiency (Ghd) Drug Segment by Application

Children

Adults

Human Growth Hormone Deficiency (Ghd) Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Growth Hormone Deficiency (Ghd) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Growth Hormone Deficiency (Ghd) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Growth Hormone Deficiency (Ghd) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Growth Hormone Deficiency (Ghd) Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Growth Hormone Deficiency (Ghd) Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Somavaratan Table 2. Major Company of Somapacitan Table 3. Major Company of TransCon-hGH Table 4. Major Company of Others Table 5. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 7. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Human Growth Hormone Deficiency (Ghd) Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2027-2032) & (K Units) Table 12. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Human Growth Hormone Deficiency (Ghd) Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 17. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Human Growth Hormone Deficiency (Ghd) Drug Industry Trends Table 27. Human Growth Hormone Deficiency (Ghd) Drug Industry Drivers Table 28. Human Growth Hormone Deficiency (Ghd) Drug Industry Opportunities and Challenges Table 29. Human Growth Hormone Deficiency (Ghd) Drug Industry Restraints Table 30. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Company (2021-2026) Table 32. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Company (2021-2026) & (K Units) Table 33. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Company (2021-2026) Table 34. Global Human Growth Hormone Deficiency (Ghd) Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Human Growth Hormone Deficiency (Ghd) Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Human Growth Hormone Deficiency (Ghd) Drug Major Company Production Sites and Headquarters Table 37. Global Human Growth Hormone Deficiency (Ghd) Drug Company, Product Type & Application Table 38. Global Human Growth Hormone Deficiency (Ghd) Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Human Growth Hormone Deficiency (Ghd) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Human Growth Hormone Deficiency (Ghd) Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2027-2032) & (K Units) Table 59. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Human Growth Hormone Deficiency (Ghd) Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 64. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Pharmaceutical Industries, Ltd Company Information Table 74. Teva Pharmaceutical Industries, Ltd Business Overview Table 75. Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 77. Teva Pharmaceutical Industries, Ltd Recent Development Table 78. Merck KGaA Company Information Table 79. Merck KGaA Business Overview Table 80. Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 82. Merck KGaA Recent Development Table 83. Eli Lilly and Company Company Information Table 84. Eli Lilly and Company Business Overview Table 85. Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 87. Eli Lilly and Company Recent Development Table 88. Versartis Inc. Company Information Table 89. Versartis Inc. Business Overview Table 90. Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 92. Versartis Inc. Recent Development Table 93. Strongbridge Biopharma Company Information Table 94. Strongbridge Biopharma Business Overview Table 95. Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 97. Strongbridge Biopharma Recent Development Table 98. Sandoz International GmbH (Novartis AG) Company Information Table 99. Sandoz International GmbH (Novartis AG) Business Overview Table 100. Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 102. Sandoz International GmbH (Novartis AG) Recent Development Table 103. Pfizer Inc Company Information Table 104. Pfizer Inc Business Overview Table 105. Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 107. Pfizer Inc Recent Development Table 108. Opko Health, Inc. Company Information Table 109. Opko Health, Inc. Business Overview Table 110. Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 112. Opko Health, Inc. Recent Development Table 113. Novo Nordisk A/S Company Information Table 114. Novo Nordisk A/S Business Overview Table 115. Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 117. Novo Nordisk A/S Recent Development Table 118. LG Life Sciences Company Information Table 119. LG Life Sciences Business Overview Table 120. LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 122. LG Life Sciences Recent Development Table 123. Ipsen S.A. Company Information Table 124. Ipsen S.A. Business Overview Table 125. Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 127. Ipsen S.A. Recent Development Table 128. GeneScience Pharmaceuticals Co. Ltd Company Information Table 129. GeneScience Pharmaceuticals Co. Ltd Business Overview Table 130. GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 132. GeneScience Pharmaceuticals Co. Ltd Recent Development Table 133. Genentech, Inc (Roche) Company Information Table 134. Genentech, Inc (Roche) Business Overview Table 135. Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 137. Genentech, Inc (Roche) Recent Development Table 138. Ferring Pharmaceuticals Company Information Table 139. Ferring Pharmaceuticals Business Overview Table 140. Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 142. Ferring Pharmaceuticals Recent Development Table 143. EMD Serono Inc. Company Information Table 144. EMD Serono Inc. Business Overview Table 145. EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 147. EMD Serono Inc. Recent Development Table 148. Ascendis Pharma A/S Company Information Table 149. Ascendis Pharma A/S Business Overview Table 150. Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 152. Ascendis Pharma A/S Recent Development Table 153. AnkeBio Co. Ltd Company Information Table 154. AnkeBio Co. Ltd Business Overview Table 155. AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 157. AnkeBio Co. Ltd Recent Development Table 158. North America Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026) & (K Units) Table 160. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Country (2021-2026) Table 161. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Forecast by Country (2027-2032) & (K Units) Table 162. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share Forecast by Country (2027-2032) Table 163. North America Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. North America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country (2021-2026) & (US$ Million) Table 165. North America Human Growth Hormone Deficiency (Ghd) Drug Market Share by Country (2021-2026) Table 166. North America Human Growth Hormone Deficiency (Ghd) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. North America Human Growth Hormone Deficiency (Ghd) Drug Market Share Forecast by Country (2027-2032) Table 168. Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026) & (K Units) Table 170. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Country (2021-2026) Table 171. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Forecast by Country (2027-2032) & (K Units) Table 172. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share Forecast by Country (2027-2032) Table 173. Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country (2021-2026) & (US$ Million) Table 175. Europe Human Growth Hormone Deficiency (Ghd) Drug Market Share by Country (2021-2026) Table 176. Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Europe Human Growth Hormone Deficiency (Ghd) Drug Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026) & (K Units) Table 180. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Country (2021-2026) Table 181. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Forecast by Country (2027-2032) & (K Units) Table 182. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country (2021-2026) & (US$ Million) Table 185. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Share by Country (2021-2026) Table 186. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Share Forecast by Country (2027-2032) Table 188. Latin America Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 189. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026) & (K Units) Table 190. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Country (2021-2026) Table 191. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales Forecast by Country (2027-2032) & (K Units) Table 192. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share Forecast by Country (2027-2032) Table 193. Latin America Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Latin America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country (2021-2026) & (US$ Million) Table 195. Latin America Human Growth Hormone Deficiency (Ghd) Drug Market Share by Country (2021-2026) Table 196. Latin America Human Growth Hormone Deficiency (Ghd) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Latin America Human Growth Hormone Deficiency (Ghd) Drug Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026) & (K Units) Table 200. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Country (2021-2026) Table 201. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Forecast by Country (2027-2032) & (K Units) Table 202. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share Forecast by Country (2027-2032) Table 203. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country (2021-2026) & (US$ Million) Table 205. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Share by Country (2021-2026) Table 206. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Share Forecast by Country (2027-2032) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Human Growth Hormone Deficiency (Ghd) Drug Distributors List Table 211. Human Growth Hormone Deficiency (Ghd) Drug Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Human Growth Hormone Deficiency (Ghd) Drug Image Figure 2. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Growth Hormone Deficiency (Ghd) Drug Sales (2021-2032) & (K Units) Figure 5. Somavaratan Image Figure 6. Global Somavaratan Sales YoY Growth (2021-2032) & (K Units) Figure 7. Somapacitan Image Figure 8. Global Somapacitan Sales YoY Growth (2021-2032) & (K Units) Figure 9. TransCon-hGH Image Figure 10. Global TransCon-hGH Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Human Growth Hormone Deficiency (Ghd) Drug Market Share by Type 2025 VS 2032 Figure 15. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Human Growth Hormone Deficiency (Ghd) Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Children Image Figure 28. Global Children Sales YoY Growth (2021-2032) & (K Units) Figure 29. Adults Image Figure 30. Global Adults Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Human Growth Hormone Deficiency (Ghd) Drug Market Share by Application 2025 VS 2032 Figure 33. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Human Growth Hormone Deficiency (Ghd) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Human Growth Hormone Deficiency (Ghd) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Human Growth Hormone Deficiency (Ghd) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Human Growth Hormone Deficiency (Ghd) Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Human Growth Hormone Deficiency (Ghd) Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Somavaratan
  • Somapacitan
  • TransCon-hGH
  • Others
Applications
  • Children
  • Adults
Companies covered
  • Teva Pharmaceutical Industries, Ltd
  • Merck KGaA
  • Eli Lilly and Company
  • Versartis Inc.
  • Strongbridge Biopharma
  • Sandoz International GmbH (Novartis AG)
  • Pfizer Inc
  • Opko Health, Inc.
  • Novo Nordisk A/S
  • LG Life Sciences
  • Ipsen S.A.
  • GeneScience Pharmaceuticals Co. Ltd
  • Genentech, Inc (Roche)
  • Ferring Pharmaceuticals
  • EMD Serono Inc.
  • Ascendis Pharma A/S
  • AnkeBio Co. Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Growth Hormone Deficiency (Ghd) Drug Market by Type
  6. 1.3.1 Somavaratan
  7. 1.3.2 Somapacitan
  8. 1.3.3 TransCon-hGH
  9. 1.3.4 Others
  10. 1.4 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size by Type
  11. 1.4.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Human Growth Hormone Deficiency (Ghd) Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Human Growth Hormone Deficiency (Ghd) Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Human Growth Hormone Deficiency (Ghd) Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Human Growth Hormone Deficiency (Ghd) Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Growth Hormone Deficiency (Ghd) Drug Industry Trends
  2. 2.2 Human Growth Hormone Deficiency (Ghd) Drug Industry Drivers
  3. 2.3 Human Growth Hormone Deficiency (Ghd) Drug Industry Opportunities and Challenges
  4. 2.4 Human Growth Hormone Deficiency (Ghd) Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Growth Hormone Deficiency (Ghd) Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Human Growth Hormone Deficiency (Ghd) Drug Price (2021-2026)
  4. 3.4 Global Human Growth Hormone Deficiency (Ghd) Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Growth Hormone Deficiency (Ghd) Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Human Growth Hormone Deficiency (Ghd) Drug Company, Product Type & Application
  7. 3.7 Global Human Growth Hormone Deficiency (Ghd) Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Growth Hormone Deficiency (Ghd) Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Growth Hormone Deficiency (Ghd) Drug Tier 1, Tier 2, and Tier 3
4 Human Growth Hormone Deficiency (Ghd) Drug Regional Status and Outlook
  1. 4.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Growth Hormone Deficiency (Ghd) Drug Historic Market Size by Region
  3. 4.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Growth Hormone Deficiency (Ghd) Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Growth Hormone Deficiency (Ghd) Drug Forecasted Market Size by Region
  7. 4.3.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Growth Hormone Deficiency (Ghd) Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Growth Hormone Deficiency (Ghd) Drug by Application
  1. 5.1 Human Growth Hormone Deficiency (Ghd) Drug Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.2 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size by Application
  5. 5.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Human Growth Hormone Deficiency (Ghd) Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Human Growth Hormone Deficiency (Ghd) Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Human Growth Hormone Deficiency (Ghd) Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries, Ltd
  2. 6.1.1 Teva Pharmaceutical Industries, Ltd Company Information
  3. 6.1.2 Teva Pharmaceutical Industries, Ltd Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries, Ltd Recent Developments
  7. 6.2 Merck KGaA
  8. 6.2.1 Merck KGaA Company Information
  9. 6.2.2 Merck KGaA Business Overview
  10. 6.2.3 Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  12. 6.2.5 Merck KGaA Recent Developments
  13. 6.3 Eli Lilly and Company
  14. 6.3.1 Eli Lilly and Company Company Information
  15. 6.3.2 Eli Lilly and Company Business Overview
  16. 6.3.3 Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  18. 6.3.5 Eli Lilly and Company Recent Developments
  19. 6.4 Versartis Inc.
  20. 6.4.1 Versartis Inc. Company Information
  21. 6.4.2 Versartis Inc. Business Overview
  22. 6.4.3 Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  24. 6.4.5 Versartis Inc. Recent Developments
  25. 6.5 Strongbridge Biopharma
  26. 6.5.1 Strongbridge Biopharma Company Information
  27. 6.5.2 Strongbridge Biopharma Business Overview
  28. 6.5.3 Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  30. 6.5.5 Strongbridge Biopharma Recent Developments
  31. 6.6 Sandoz International GmbH (Novartis AG)
  32. 6.6.1 Sandoz International GmbH (Novartis AG) Company Information
  33. 6.6.2 Sandoz International GmbH (Novartis AG) Business Overview
  34. 6.6.3 Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  36. 6.6.5 Sandoz International GmbH (Novartis AG) Recent Developments
  37. 6.7 Pfizer Inc
  38. 6.7.1 Pfizer Inc Company Information
  39. 6.7.2 Pfizer Inc Business Overview
  40. 6.7.3 Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  42. 6.7.5 Pfizer Inc Recent Developments
  43. 6.8 Opko Health, Inc.
  44. 6.8.1 Opko Health, Inc. Company Information
  45. 6.8.2 Opko Health, Inc. Business Overview
  46. 6.8.3 Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  48. 6.8.5 Opko Health, Inc. Recent Developments
  49. 6.9 Novo Nordisk A/S
  50. 6.9.1 Novo Nordisk A/S Company Information
  51. 6.9.2 Novo Nordisk A/S Business Overview
  52. 6.9.3 Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  54. 6.9.5 Novo Nordisk A/S Recent Developments
  55. 6.10 LG Life Sciences
  56. 6.10.1 LG Life Sciences Company Information
  57. 6.10.2 LG Life Sciences Business Overview
  58. 6.10.3 LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  60. 6.10.5 LG Life Sciences Recent Developments
  61. 6.11 Ipsen S.A.
  62. 6.11.1 Ipsen S.A. Company Information
  63. 6.11.2 Ipsen S.A. Business Overview
  64. 6.11.3 Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  66. 6.11.5 Ipsen S.A. Recent Developments
  67. 6.12 GeneScience Pharmaceuticals Co. Ltd
  68. 6.12.1 GeneScience Pharmaceuticals Co. Ltd Company Information
  69. 6.12.2 GeneScience Pharmaceuticals Co. Ltd Business Overview
  70. 6.12.3 GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  72. 6.12.5 GeneScience Pharmaceuticals Co. Ltd Recent Developments
  73. 6.13 Genentech, Inc (Roche)
  74. 6.13.1 Genentech, Inc (Roche) Company Information
  75. 6.13.2 Genentech, Inc (Roche) Business Overview
  76. 6.13.3 Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  78. 6.13.5 Genentech, Inc (Roche) Recent Developments
  79. 6.14 Ferring Pharmaceuticals
  80. 6.14.1 Ferring Pharmaceuticals Company Information
  81. 6.14.2 Ferring Pharmaceuticals Business Overview
  82. 6.14.3 Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  84. 6.14.5 Ferring Pharmaceuticals Recent Developments
  85. 6.15 EMD Serono Inc.
  86. 6.15.1 EMD Serono Inc. Company Information
  87. 6.15.2 EMD Serono Inc. Business Overview
  88. 6.15.3 EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  90. 6.15.5 EMD Serono Inc. Recent Developments
  91. 6.16 Ascendis Pharma A/S
  92. 6.16.1 Ascendis Pharma A/S Company Information
  93. 6.16.2 Ascendis Pharma A/S Business Overview
  94. 6.16.3 Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  96. 6.16.5 Ascendis Pharma A/S Recent Developments
  97. 6.17 AnkeBio Co. Ltd
  98. 6.17.1 AnkeBio Co. Ltd Company Information
  99. 6.17.2 AnkeBio Co. Ltd Business Overview
  100. 6.17.3 AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  102. 6.17.5 AnkeBio Co. Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country
  2. 7.1.1 North America Human Growth Hormone Deficiency (Ghd) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Human Growth Hormone Deficiency (Ghd) Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country
  6. 7.2.1 North America Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Growth Hormone Deficiency (Ghd) Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country
  2. 8.1.1 Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country
  6. 8.2.1 Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Country
  2. 9.1.1 Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country
  2. 10.1.1 South America Human Growth Hormone Deficiency (Ghd) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Human Growth Hormone Deficiency (Ghd) Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country
  6. 10.2.1 South America Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Growth Hormone Deficiency (Ghd) Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Country
  2. 11.1.1 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Growth Hormone Deficiency (Ghd) Drug Value Chain Analysis
  2. 12.1.1 Human Growth Hormone Deficiency (Ghd) Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Growth Hormone Deficiency (Ghd) Drug Production Mode & Process
  7. 12.2 Human Growth Hormone Deficiency (Ghd) Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Growth Hormone Deficiency (Ghd) Drug Distributors
  10. 12.2.3 Human Growth Hormone Deficiency (Ghd) Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst